Brandon Hants

Brandon Hants serves as Chief Financial Officer of TRexBio. He brings more than 25 years of experience working in finance, accounting, and other corporate functions within the biotech industry. Prior to TRexBio, Mr. Hants served as Chief Financial Officer at Applied Molecular Transport, a clinical stage biotherapeutics company that developed a pipeline of novel oral biologic product candidates. Prior to that, he held various roles at Singulex, Inc., an immunodiagnostics company, including Chief Financial Officer and Vice President, Finance and Operations. Prior to Singulex, Mr. Hants held roles of increasing responsibility at Novartis Vaccines & Diagnostics and Genentech.

Mr. Hants holds a BS in Cell and Developmental Biology from the University of California, Santa Barbara, and an MBA from the University of San Francisco.